XML 62 R47.htm IDEA: XBRL DOCUMENT v3.25.1
DISCONTINUED OPERATIONS - Schedule of Operations from Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Loss from discontinued operations, net of income taxes $ 0 $ (2,149)
Total revenues | Rezafungin    
Revenues:    
Total revenues   7,490
Operating expenses:    
Cost of product revenue   1,563
Research and development   5,674
Selling, general and administrative   2,402
Total operating expenses   9,639
Loss from discontinued operations, net of income taxes   $ (2,149)